Related Experiment Video
Updated: Jul 16, 2025

Author Spotlight: Advancing Research on Candida albicans Biofilm-Associated Prosthetic Joint Infections
Published on: February 2, 2024
Post-COVID Fungal Osteomyelitis-Another Killer.
Surender Pal Singh Sodhi1, Gursimrat Kaur Brar1, Deepinder Pal Singh Sodhi2
1Department of Oral and Maxillofacial Surgery, Dasmesh Institute of Research and Dental Sciences, Faridkot, Punjab, India.
Fungal co-infections during COVID-19 pandemics may be overlooked. This study highlights cases of fungal infections in the maxilla and orbit following coronavirus disease 2019 (COVID-19) treatment.
Area of Science:
- Infectious Diseases
- Mycology
- Ophthalmology
- Otorhinolaryngology
Background:
- The COVID-19 pandemic, caused by SARS-CoV-2, has led to widespread global health challenges.
- Previous outbreaks, such as SARS, indicated a potential for fungal co-infections.
- There is a concern that fungal co-infections in COVID-19 patients may be underdiagnosed or misdiagnosed.
Purpose of the Study:
- To investigate the potential for missed or misdiagnosed fungal co-infections in COVID-19 patients.
- To report a case series of patients with fungal infections of the maxilla and orbit following COVID-19.
- To present successful treatment outcomes and follow-up for these cases.
Main Methods:
- Retrospective analysis of global SARS data.
- Case series reporting of fungal infections in the maxilla and orbit.
- Documentation of successful treatment and regular follow-up.
Main Results:
- A retrospective analysis suggests fungal co-infections associated with COVID-19 might be missed or misdiagnosed.
- The study presents cases of fungal infections affecting the maxilla and orbit in patients treated for COVID-19.
- These patients were successfully treated and are under regular follow-up.
Conclusions:
- Fungal co-infections are a potential complication of COVID-19 that warrants attention.
- Early identification and management of fungal infections in the maxilla and orbit are crucial for COVID-19 patients.
- Successful treatment outcomes are achievable with appropriate medical care and monitoring.
Related Concept Videos
Endocarditis II: Clinical Features of Infective Endocarditis
Pneumonia II: Pathophysiology
Pneumonia III: Complications and Assessment
Endocarditis I: Introduction
Fungal Phylum Microsporidia
Infection
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...

